New Imaging Score May Predict Chemo Benefit in Early OPSCC New Imaging Score May Predict Chemo Benefit in Early OPSCC
If validated, this scoring system could help identify patients with oropharyngeal squamous cell carcinoma who can skip chemo. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NIDCR  Requests Input on Proposed Research Initiatives
NIDCR Home   |   Careers   |   Contact Announcements The National Institute of Dental and Craniofacial Research (NIDCR) requests your input on six proposed concepts (research initiatives) presented at the September 2022 National Advisory Dental and Craniofacial Research Council meeting. The six initiatives are listed below. To read the full initiative descriptions and provide input, please visit: NIDCR Requests Input on FY 2023 Proposed Research Initiatives   Initiatives: ...
Source: NIDCR Science News - October 6, 2022 Category: Dentistry Source Type: news

Symptoms Predict Therapy Failure, Death in Oropharyngeal Cancer Symptoms Predict Therapy Failure, Death in Oropharyngeal Cancer
Specifically, shortness-of-breath and dysphagia can help guide surveillance after radiotherapy. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 2, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Patients With Head/Neck Cancer See Lower Stroke Risk With Initial Surgery
(MedPage Today) -- In oropharyngeal squamous cell carcinoma (OPSCC), the type of initial treatment appears to influence the likelihood of stroke in the years afterward, researchers said. A population-based study of U.S. veterans treated for OPSCC... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - August 12, 2022 Category: Radiology Source Type: news

Best Approach for Low-risk HPV+ Oropharynx Cancers? Best Approach for Low-risk HPV+ Oropharynx Cancers?
The question of whether primary transoral surgery or radiation is a better option for patients with low-risk HPV-related oropharyngeal cancers is still unanswered, despite new results from ORATOR2.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 12, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

HPV-Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity
FRIDAY, July 15, 2022 -- Non-Hispanic White men are disproportionately affected by late-stage human papillomavirus (HPV)-related oropharyngeal cancer (OPC), but cancer-specific mortality (CSM) is elevated among Hispanic and non-Hispanic Black men,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 15, 2022 Category: Pharmaceuticals Source Type: news

Science Saturday: Uncovering disparities in local communities -- the case of the HPV vaccine
Where you live may affect whether you receive the cancer-preventing HPV vaccine, suggests a new study published in the journal Vaccine. The first human papillomavirus (HPV) vaccine was approved for use in the U.S. by the Food and Drug Administration in 2006. According to the National Cancer Institute, the types of HPV the current vaccine covers are those which cause 90% of genital warts, as many as 90% of cervical cancers, as well as a majority of oropharyngeal (a type of throat cancer), anal, penile, vaginal and vulvar cancers.… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 30, 2022 Category: Research Source Type: news

Mayo Clinic Minute: Improved treatments for head and neck cancer
April is Sexually Transmitted Infections Awareness Month. About 70% of cancers in the oropharynx, which includes the tonsils, soft palate and base of the tongue, are linked to the HPV virus, according to the Centers for Disease Control and Prevention. So it's important to talk to your health care team about the HPV vaccine, especially if you are 26 years old or younger. In addition to the importance of the HPV vaccine, you can lower… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 25, 2022 Category: Databases & Libraries Source Type: news

How Is Oropharynx Cancer Diagnosed?
Title: How Is Oropharynx Cancer Diagnosed?Category: Diseases and ConditionsCreated: 4/14/2022 12:00:00 AMLast Editorial Review: 4/14/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 14, 2022 Category: Cancer & Oncology Source Type: news

What Is Oropharyngeal Cancer?
Title: What Is Oropharyngeal Cancer?Category: Diseases and ConditionsCreated: 4/5/2022 12:00:00 AMLast Editorial Review: 4/5/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 5, 2022 Category: Cancer & Oncology Source Type: news

Can Liquid Biopsy Predict Oropharyngeal Cancer Recurrence? Can Liquid Biopsy Predict Oropharyngeal Cancer Recurrence?
Performing a routine liquid biopsy test for HPV DNA may allow recurrence of oropharyngeal squamous cell carcinoma to be identified before clinical signs develop, a new study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Imaging Identifies Candidates for Oropharynx Cancer De-escalation Imaging Identifies Candidates for Oropharynx Cancer De-escalation
Oropharynx cancer patients able to undergo radiotherapy de-escalation may be identified via serial FDG-PET scans, a new study finds.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 1, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

De-escalation of Radiotherapy for HPV-Associated Oropharyngeal Cancer De-escalation of Radiotherapy for HPV-Associated Oropharyngeal Cancer
For patients with HPV-positive oropharyngeal cancer undergoing definitive concurrent chemoradiotherapy, reduced radiation dose and volume to elective treatment regions yields ' uncompromised ' disease control with favorable toxicity, a study suggests.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - January 27, 2022 Category: Radiology Tags: Hematology-Oncology News Source Type: news

' Outstanding' Outcomes: Reduced Radiation in Oropharynx Cancer'Outstanding' Outcomes: Reduced Radiation in Oropharynx Cancer
Comparable progression-free survival was observed in intermediate-risk patients with HPV and oropharynx cancer who received less intense postoperative radiation therapy, without chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 3, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Oropharyngeal Cancer Up About 3% Among Men Oropharyngeal Cancer Up About 3% Among Men
In addition, about 80% of these cancers were in men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 3, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news